It is hard to get much of a reputation if nobody knows you're around, and that has definitely been the case for mycoplasma genitalium, the tiny bacteria estimated to be more prevalent than the bug that causes gonorrhea but ...
Aug 5, 2019
0
3
New research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibiotics inhibit cancer in the skin in patients with rare type of lymphoma.
Jul 25, 2019
0
0
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer. This is the conclusion reached by the members of Screenwide research group, formed ...
Jun 17, 2019
0
1
A questionnaire aimed at assessing how well community oncologists understand "molecular profiling" results from tumor specimens found that 69 percent of participants either said they don't know the answers, or they responded ...
May 30, 2019
0
0
Diseases caused by genetic changes could be detected more readily thanks to an advance in DNA analysis software.
May 30, 2019
0
76
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.
Aug 15, 2018
0
42
Researchers at The University of Western Australia and King Edward Memorial Hospital have teamed up with an Australian molecular diagnostics company to develop a new low-cost test to identify women at risk of delivering a ...
Aug 13, 2018
0
3
A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer. The new guidelines reflect recent advancements, as ...
Jan 23, 2018
0
3
A new study assessed the effects of a SLC6A15 gene variant on resting-state brain function in patients with major depressive disorder (MDD), comparing the results with those in healthy individuals. Based on the results of ...
Dec 5, 2017
0
0
Pharmaceutical companies developing Orphan Drugs are increasingly partnering with direct-to-consumer (DTC) genetic testing firms to identify individuals with rare diseases, in a trend that is raising concerns related to privacy, ...
Sep 27, 2017
0
0
